Payne BA, Hanson C, Sharma S, Magee LA, von Dadelszen P. Epidemiology of the hypertensive disorders of pregnancy, In Magee LA, von Dadelszen P, Stones W, Mathai M, editors The FIGO Textbook of Pregnancy Hypertension. United Kingdom. The Global Library of Women’s Medicine: 2016. 63–74.

Chappell LC, Cluver CA, Kingdom J, Tong S. Pre-eclampsia. Lancet. 2021;398:341–54.

Article  CAS  PubMed  Google Scholar 

Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40:213–20.

Article  PubMed  Google Scholar 

Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol. 2012;206:470–5.

Article  PubMed  Google Scholar 

Keepanasseril A, Monarrez-Espino J, Vadivelu P, Kumar Maurya D. Risk factors of pulmonary edema in women with preeclampsia from south India: a case-control study. J Hum Hypertens. 2020;34:727–34.

Article  CAS  PubMed  Google Scholar 

McDermott M, Miller EC, Rundek T, Hurn PD, Bushnell CD. Preeclampsia: Association With Posterior Reversible Encephalopathy Syndrome and Stroke. Stroke. 2018;49:524–30.

Article  PubMed  PubMed Central  Google Scholar 

Hauspurg A, Jeyabalan A. Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2022;226:S1211–S1221.

Article  CAS  PubMed  Google Scholar 

Cairns AE, Pealing L, Duffy JMN, Roberts N, Tucker KL, Leeson P, et al. Postpartum management of hypertensive disorders of pregnancy: a systematic review. BMJ Open. 2017;7:e018696.

Article  PubMed  PubMed Central  Google Scholar 

National Institute for Health and Care Excellence Hypertension in pregnancy: diagnosis and management. [Internet] [London]: NICE; 2019 [updated 2023 Apr; cited 2023 Apr 10](NICE guideline NG133). Available from https://www.nice.org.uk/guidance/ng133.

Kumar NR, Hirshberg A, Srinivas SK. Best Practices for Managing Postpartum Hypertension. Curr Obstet Gynecol Rep. 2022;11:159–68.

Article  PubMed  PubMed Central  Google Scholar 

Sharma KJ, Greene N, Kilpatrick SJ. Oral labetalol compared to oral nifedipine for postpartum hypertension: A randomized controlled trial. Hypertens Pregnancy. 2017;36:44–47.

Article  CAS  PubMed  Google Scholar 

Veena P, Perivela L, Raghavan SS. Furosemide in postpartum management of severe preeclampsia: A randomized controlled trial. Hypertens Pregnancy. 2017;36:84–89.

Article  CAS  PubMed  Google Scholar 

Ainuddin J, Javed F, Kazi S. Oral labetalol versus oral nifedipine for the management of postpartum hypertension a randomized control trial. Pak J Med Sci. 2019;35:1428–33.

Article  PubMed  PubMed Central  Google Scholar 

Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–31.

Google Scholar 

ACOG Committee Opinion No. 767 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period. Obstet Gynecol 2019;133:e174–80.

Watson DL, Bhatia RK, Norman GS, Brindley BA, Sokol RJ. Bromocriptine mesylate for lactation suppression: a risk for postpartum hypertension? Obstet Gynecol. 1989;74:573–6.

CAS  PubMed  Google Scholar 

Kirschen GW, Hoyt K, Johnson E, Patel S. Eclampsia with RCVS: Postpartum seizure provoked by methergine. Pregnancy Hypertens. 2022;27:131–3.

Article  PubMed  PubMed Central  Google Scholar 

Powles K, Gandhi S. Postpartum hypertension. CMAJ. 2017;189:E913.

Article  PubMed  PubMed Central  Google Scholar 

Joshi A, Beyuo T, Oppong SA, Moyer CA, Lawrence ER. Preeclampsia knowledge among postpartum women treated for preeclampsia and eclampsia at Korle Bu Teaching Hospital in Accra, Ghana. BMC Pregnancy Childbirth. 2020;20:625.

Article  PubMed  PubMed Central  Google Scholar 

Firoz T, Sanghvi H, Merialdi M, von Dadelszen P. Pre-eclampsia in low and middle income countries. Best practice & research. Clin Obstetrics Gynaecol. 2011;25:537–48.

Google Scholar 

Anderson PO. Treating Hypertension During Breastfeeding. Breastfeed Med. 2018;13:95–6.

Article  PubMed  Google Scholar 

Pucci G, Battista F, Schillaci G. Effects of antihypertensive drugs on central blood pressure: new evidence, more challenges. Hypertens Res. 2014;37:10–2.

Article  CAS  PubMed  Google Scholar 

McGaughey TJ, Fletcher EA, Shah SA. Impact of Antihypertensive Agents on Central Systolic Blood Pressure and Augmentation Index: A Meta-Analysis. Am J Hypertens. 2016;29:448–57.

Article  CAS  PubMed  Google Scholar 

Misra A. Ethnic-Specific Criteria for Classification of Body Mass Index: A Perspective for Asian Indians and American Diabetes Association Position Statement. Diabetes Technol Ther. 2015;17:667–71.

Article  PubMed  PubMed Central  Google Scholar 

Cheymol G. Clinical pharmacokinetics of drugs in obesity. An update. Clin Pharmacokinet. 1993;25:103–14.

Article  CAS  PubMed  Google Scholar 

Feghali M, Venkataramanan R, Caritis S. Pharmacokinetics of drugs in pregnancy. Semin Perinatol. 2015;39:512–9.

Article  PubMed  PubMed Central  Google Scholar 

Mulrenin IR, Garcia JE, Fashe MM, Loop MS, Daubert MA, Urrutia RP, et al. The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions. Expert Opin Drug Metab Toxicol. 2021;17:1261–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fischer JH, Sarto GE, Hardman J, Endres L, Jenkins TM, Kilpatrick SJ, et al. Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy. Clin Pharmacokinet. 2014;53:373–83.

Article  CAS  PubMed  PubMed Central  Google Scholar